2020
DOI: 10.1093/ecco-jcc/jjaa193
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review

Abstract: Introduction Lymphoma is a dreaded complication of inflammatory bowel diseases (IBD). Knowledge about lymphoma in patients with IBD is limited to epidemiological data and risk factors description. We performed a systematic review to describe clinical characteristics and prognosis of lymphoma in patients with IBD. Methods Electronic databases were searched up to 1 st June 2020. All published clinical characteristics of lymphom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 58 publications
0
13
0
Order By: Relevance
“…Knowledge about lymphoma in patients with IBD is limited to epidemiological data and the description of risk factors [131]. However, clinicians should bear in mind that Crohn's disease may be complicated by neoplasia such as adenocarcinomas or lymphomas, especially if the disease duration is long and the patient is under immunosuppressive therapy [132]. The prognosis for lymphomas occurring in IBD appears to be good and what is expected, irrespective of the exposure to biologics and/or immunosuppressants [133].…”
Section: Neoplasticmentioning
confidence: 99%
“…Knowledge about lymphoma in patients with IBD is limited to epidemiological data and the description of risk factors [131]. However, clinicians should bear in mind that Crohn's disease may be complicated by neoplasia such as adenocarcinomas or lymphomas, especially if the disease duration is long and the patient is under immunosuppressive therapy [132]. The prognosis for lymphomas occurring in IBD appears to be good and what is expected, irrespective of the exposure to biologics and/or immunosuppressants [133].…”
Section: Neoplasticmentioning
confidence: 99%
“…A recent systematic review reported that NHL was the most common histological type (83.9%) in the IBD patients. Furthermore, EBV positive status was observed in a large part of lymphoma patients with IBD (44-75%) (Muller et al, 2020). Patients with IBD who receive thiopurines are likely to develop a subset of lymphoma similar to EBV-related malignant lymphoma that develops after organ transplantation.…”
Section: Involvement Of Long-term Thiopurines and Onset Of Lymphoproliferative Disorders (Lpds)mentioning
confidence: 99%
“…However, it is important to point out that direct and indirect mechanisms of virus-driven carcinogenesis are not mutually exclusive and some tissues may be equally dependent on both mechanisms for oncogenic transformation, such as the liver and stomach [13]. While current evidence strongly suggests a role of certain viruses, e.g., Epstein-Barr virus (EBV) in the pathogenesis of lymphoma in IBD patients [34] or human papillomavirus (HPV) in cervical cancer [35], the role of these and other viruses in gastrointestinal cancer remains less clear.…”
Section: Virusesmentioning
confidence: 99%